BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7524739)

  • 1. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor.
    Issaad C; Vainchenker W
    Blood; 1994 Nov; 84(10):3447-56. PubMed ID: 7524739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
    Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID; Andrews RG; Zsebo KM
    Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential.
    Lu L; Xiao M; Shen RN; Grigsby S; Broxmeyer HE
    Blood; 1993 Jan; 81(1):41-8. PubMed ID: 7678069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
    Strife A; Wisniewski D; Liu C; Lambek CL; Darzynkiewicz Z; Silver RT; Clarkson B
    Mol Cancer Res; 2003 Jan; 1(3):176-85. PubMed ID: 12556557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
    Pharr PN; Hankins D; Hofbauer A; Lodish HF; Longmore GD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):938-42. PubMed ID: 7679218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD; Amin S; Weng LJ; Civin CI
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.
    Baines P; Bowen D; Jacobs A
    Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor.
    Migliaccio G; Migliaccio AR; Druzin ML; Giardina PJ; Zsebo KM; Adamson JW
    Blood; 1992 May; 79(10):2620-7. PubMed ID: 1375106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ; Hijiya N; Catani L; DeRiel K; Luger SM; McGlave P; Gewirtz AM
    Blood; 1992 Apr; 79(8):1956-61. PubMed ID: 1562723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum.
    Muller EW; de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
    Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.